These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31958402)

  • 21. Despite law, fewer than one in eight completed studies of drugs and biologics are reported on time on ClinicalTrials.gov.
    Law MR; Kawasumi Y; Morgan SG
    Health Aff (Millwood); 2011 Dec; 30(12):2338-45. PubMed ID: 22147862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public availability of results of trials assessing cancer drugs in the United States.
    Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
    J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creating a Program to Support Registering and Reporting Clinical Trials at Johns Hopkins University.
    Keyes A; Mayo-Wilson E; Nuamah P; Lalji A; Tetteh O; Ford DE
    Acad Med; 2021 Apr; 96(4):529-533. PubMed ID: 33060401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.
    Rayi A; Thompson S; Gloss D; Malhotra K
    Epilepsy Res; 2018 Jul; 143():1-6. PubMed ID: 29625272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responsible Parties-Is It Time to Clean Up Your ACTs?
    Vakarcs F
    Ther Innov Regul Sci; 2014 Sep; 48(5):651-657. PubMed ID: 30231451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
    Pranić S; Marušić A
    J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commitments by the biopharmaceutical industry to clinical trial transparency: the evolving environment.
    Baronikova S; Purvis J; Southam E; Beeso J; Panayi A; Winchester C
    BMJ Evid Based Med; 2019 Oct; 24(5):177-184. PubMed ID: 30898790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
    Evoniuk G; Mansi B; DeCastro B; Sykes J
    BMJ; 2017 Apr; 357():j1726. PubMed ID: 28432051
    [No Abstract]   [Full Text] [Related]  

  • 31. Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years.
    Pellat A; Boutron I; Ravaud P
    Oncologist; 2022 Nov; 27(11):e849-e855. PubMed ID: 35983949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Few comply with clinical trials reporting law.
    Cancer Discov; 2015 Jun; 5(6):OF4. PubMed ID: 25873076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The obstetrical research landscape: a cross-sectional analysis of clinical trials from 2007-2020.
    Steinberg JR; Weeks BT; Reyes GA; Conway Fitzgerald A; Zhang WY; Lindsay SE; Anderson JN; Chan K; Richardson MT; Magnani CJ; Igbinosa I; Girsen A; El-Sayed YY; Turner BE; Lyell DJ
    Am J Obstet Gynecol MFM; 2021 Jan; 3(1):100253. PubMed ID: 33043288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.
    Goldacre B; DeVito NJ; Heneghan C; Irving F; Bacon S; Fleminger J; Curtis H
    BMJ; 2018 Sep; 362():k3218. PubMed ID: 30209058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial.
    Maruani A; Boutron I; Baron G; Ravaud P
    BMJ; 2014 Sep; 349():g5579. PubMed ID: 25239625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.
    Wallach JD; Egilman AC; Dhruva SS; McCarthy ME; Miller JE; Woloshin S; Schwartz LM; Ross JS
    BMJ; 2018 May; 361():k2031. PubMed ID: 29794072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. US to impose tougher rules on reporting clinical trial data.
    McCarthy M
    BMJ; 2016 Sep; 354():i5060. PubMed ID: 27647879
    [No Abstract]   [Full Text] [Related]  

  • 38. ClinicalTrials.gov reporting: strategies for success at an academic health center.
    O'Reilly EK; Hassell NJ; Snyder DC; Natoli S; Liu I; Rimmler J; Amspacher V; Burnett BK; Parrish AB; Berglund JP; Stacy M
    Clin Transl Sci; 2015 Feb; 8(1):48-51. PubMed ID: 25387802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
    Rees CA; Pica N; Monuteaux MC; Bourgeois FT
    PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A descriptive analysis of postmarketing requirement studies and clinical trials.
    Choi L; Etchey B; Billings M; Lee C; Weil KM; Boxwell D; Edelberg H
    Pharmacoepidemiol Drug Saf; 2024 Jan; 33(1):e5725. PubMed ID: 37994284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.